UNSPSC 51331701: Amisulpride

This classification denotes a dopamine antagonist with the molecular formula C17H27N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8110R61I4U, chemically known as benzamide, 4-amino-n-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxy- but generally known as amisulpride, which bears US NIH Compound Identifier 2159. European Medicines Agency schedules Amisulpride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05458MIG.

UNSPSC 51331701 Amisulpride, a Commodity code, shows minimal alignment with recent state and local solicitation activity. The code nominally classifies a specific antipsychotic pharmaceutical, but the sole recent opportunity posted under this code is Seminole County, Florida's IFB 60459723LAS seeking procurement of naloxone (an opioid antagonist) and safe drug deactivation systems—products unrelated to amisulpride's therapeutic class and indication. The mismatch suggests either a tagging error in the county's procurement system or a fundamental disconnect between the code's pharmaceutical scope and the actual goods being purchased.

Seminole County posted the IFB on June 30, 2026, with a response deadline of July 26, 2023 (a discrepancy in the source dates that undermines the recency signal). The procurement calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bidders must submit electronically through the county's e-Procurement Portal, include all shipping and delivery costs in their proposals, and comply with drug-free workplace certification, E-Verify requirements, and specific insurance coverages. The contract offers an initial two-year term with an optional one-year renewal. No set-aside designations or disadvantaged-enterprise restrictions are noted. Given the code's narrow pharmaceutical focus and the absence of other recent amisulpride-specific opportunities, this code presents limited pursuit opportunity for vendors outside pharmaceutical supply distribution—and the single posted opportunity does not align with amisulpride procurement in any case.